Innova Captab

Innova Captab Debt

The Debt of Innova Captab (INNOVACAP.NS) as of Nov 22, 2026 is 3.44 B INR. In the previous year, Debt was 3.38 B INR — a change of 1.65% (higher).

Debt

3.44 BINR

YoY

1.65%

Last updated:

In 2026, Innova Captab's total debt was 3.44 B INR, a 1.65% change from the 3.38 B INR total debt recorded in the previous year.

The Innova Captab Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2019
858.04 M INR
Jan 1, 2020
654.59 M INR
Jan 1, 2021
454.97 M INR
Jan 1, 2022
1.99 B INR
Jan 1, 2023
2.37 B INR
Jan 1, 2024
2.45 B INR
Jan 1, 2025
3.38 B INR
Jan 1, 2026
3.44 B INR
The Innova Captab Debt history
YEARDebtYoY
3.44 BINR+1.65%
3.38 BINR+37.95%
2.45 BINR+3.43%
2.37 BINR+18.98%
1.99 BINR+337.76%
454.97 MINR-30.50%
654.59 MINR-23.71%
858.04 MINR+12.91%
759.96 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Innova Captab Stock analysis

What does Innova Captab do? Innova Captab Ltd generates revenue through its CDMO business, which offers research, product development, and manufacturing services to clients in the pharmaceutical sector. The company also earns from its domestic branded generics business, developing, manufacturing, and distributing generic formulation products under its own brand names across India via online and offline channels. Additionally, Innova Captab sells its generic drug products through various e-commerce pharmacy sites. The company's diversified portfolio includes tablets, capsules, dry syrups, dry powder injection, ointments, and liquid orals. Its international branded generic product business focuses on exporting branded generic products globally. Innova Captab's primary customers are pharmaceutical companies seeking CDMO services, Indian consumers purchasing generic medicines through retail and online pharmacies, and international buyers of branded generic products. The domestic market segment is served through branded generics sold under the company's own brand names, while the international segment targets global markets for branded generic drug exports. The company's value chain spans research and development, manufacturing, drug distribution, marketing, and exports, ensuring comprehensive coverage across the pharmaceutical industry. The company's product segments include CDMO services, domestic branded generics, and international branded generics. CDMO services are provided to pharmaceutical firms requiring outsourced research and manufacturing. Domestic branded generics are marketed in India under the company's brand names through both online and offline channels. International branded generics are exported to global markets, leveraging the company's manufacturing capabilities and product portfolio. Innova Captab's business model integrates all stages of the pharmaceutical value chain, from R&D to exports, to deliver a full-service solution for its clients and customers. Innova Captab is one of the most popular companies on Eulerpool.

Debt Details

Understanding Innova Captab's Debt Structure

Innova Captab's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Innova Captab's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Innova Captab’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Innova Captab’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Innova Captab stock

Debt of Innova Captab is 3.44 B INR in 2026.

Debt of Innova Captab changed from 3.38 B INR to 3.44 B INR, representing a 1.65% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt Innova Captab since 2006 – with annual values, charts, and detailed analysis.

Debt's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Innova Captab historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Innova Captab

All Key Metrics — Innova Captab